List of Excipients in API articaine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing articaine hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| American Genomics LLC | CYKLX | articaine hydrochloride | 87047-7852 | ACETIC ACID | 2028-08-15 |
| American Genomics LLC | CYKLX | articaine hydrochloride | 87047-7852 | BORIC ACID | 2028-08-15 |
| American Genomics LLC | CYKLX | articaine hydrochloride | 87047-7852 | EDETATE DISODIUM | 2028-08-15 |
| American Genomics LLC | CYKLX | articaine hydrochloride | 87047-7852 | MANNITOL | 2028-08-15 |
| American Genomics LLC | CYKLX | articaine hydrochloride | 87047-7852 | SODIUM ACETATE | 2028-08-15 |
| Septodont Inc | ZORCAINE | articaine hydrochloride and epinephrine | 0362-0830 | SODIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing articaine hydrochloride
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| HANSAmed Inc | articaine hydrochloride, epinephrine bitartrate | 52120-200 | SODIUM CHLORIDE |
| HANSAmed Inc | articaine hydrochloride, epinephrine bitartrate | 52120-200 | SODIUM HYDROXIDE |
| HANSAmed Inc | articaine hydrochloride, epinephrine bitartrate | 52120-200 | SODIUM METABISULFITE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for articaine hydrochloride
Excipient focus: ACETIC ACID
articaine hydrochloride drug variants containing ACETIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| American Genomics LLC | articaine hydrochloride | 87047-7852 |
| >Company | >Ingredient | >NDC |
articaine hydrochloride drug variants not containing ACETIC ACID
Excipient focus: BORIC ACID
articaine hydrochloride drug variants containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| American Genomics LLC | articaine hydrochloride | 87047-7852 |
| >Company | >Ingredient | >NDC |
articaine hydrochloride drug variants not containing BORIC ACID
Excipient focus: EDETATE DISODIUM
articaine hydrochloride drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| American Genomics LLC | articaine hydrochloride | 87047-7852 |
| >Company | >Ingredient | >NDC |
articaine hydrochloride drug variants not containing EDETATE DISODIUM
Excipient focus: MANNITOL
articaine hydrochloride drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| American Genomics LLC | articaine hydrochloride | 87047-7852 |
| >Company | >Ingredient | >NDC |
articaine hydrochloride drug variants not containing MANNITOL
Excipient focus: SODIUM ACETATE
articaine hydrochloride drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| American Genomics LLC | articaine hydrochloride | 87047-7852 |
| >Company | >Ingredient | >NDC |
articaine hydrochloride drug variants not containing SODIUM ACETATE
Excipient focus: SODIUM CHLORIDE
articaine hydrochloride drug variants containing SODIUM CHLORIDE
articaine hydrochloride drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| American Genomics LLC | articaine hydrochloride | 87047-7852 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
articaine hydrochloride drug variants containing SODIUM HYDROXIDE
articaine hydrochloride drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| American Genomics LLC | articaine hydrochloride | 87047-7852 |
| Burkhart Dental Supply Co Inc | articaine hydrochloride, epinephrine bitartrate | 43498-816 |
| Midway Dental Supply LLC | articaine hydrochloride, epinephrine bitartrate | 72304-015 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METABISULFITE
articaine hydrochloride drug variants containing SODIUM METABISULFITE
articaine hydrochloride drug variants not containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| American Genomics LLC | articaine hydrochloride | 87047-7852 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
articaine hydrochloride drug variants containing WATER
articaine hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| American Genomics LLC | articaine hydrochloride | 87047-7852 |
| HANSAmed Inc | articaine hydrochloride, epinephrine bitartrate | 52120-200 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch